Previous 10 | Next 10 |
Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts PR Newswire – Maintains Minority Equity Stake in Ciitizen – – Anticipated Total Cash Savings of Approximately $90 -100 Million on an Annualized Basis – ...
2023-12-05 05:00:00 ET Now is a great time to load up on growth stocks because they may be among the first to benefit in the next bull market. We've already seen some of the biggest ones -- such as Amazon and Apple -- take off as indexes rallied in recent weeks. Buying these longtim...
2023-11-15 16:44:23 ET More on Invitae Invitae Corporation 2023 Q3 - Results - Earnings Call Presentation Invitae Corporation (NVTA) Q3 2023 Earnings Call Transcript Invitae Non-GAAP EPS of -$0.10 beats by $0.22, revenue of $121.24M in-line Invitae Q3 2023 Ea...
2023-11-09 00:15:18 ET Image source: The Motley Fool. Invitae (NYSE: NVTA) Q3 2023 Earnings Call Nov 08, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Invitae (NVTA) Q3 2023 Earnings Call Transcript
2023-11-08 21:22:07 ET Invitae Corporation (NVTA) Q3 2023 Earnings Conference Call November 8, 2023 04:30 PM ET Company Participants Hoki Luk - VP, IR and Corporate Development Ken Knight - President & CEO Ana Schrank - CFO Conference Call Participants ...
2023-11-08 16:02:37 ET More on Invitae Invitae Q3 2023 Earnings Preview Biggest stock movers today: Arch Resources, Coinbase Global and more Seeking Alpha’s Quant Rating on Invitae Historical earnings data for Invitae Financial information for ...
Invitae Reports Third Quarter 2023 Financial Results PR Newswire Reported revenue of $121.2 million , a year-over-year decrease of 9%; on a pro forma basis, taking into account exited businesses and geographies, revenue increased approximately 4% Gross margin of 32.2% an...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Invitae Corporation (NVTA) is expected to report $-0.3 for Q3 2023
Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships PR Newswire – Helps to detect circulating tumor DNA (ctDNA) as a biomarker in clinical research and clinical trials for solid tumor malignancies –...
News, Short Squeeze, Breakout and More Instantly...
Thursday, Labcorp (NYSE:LH) reported first-quarter sales increased 4.6% to $3.18 billion, beating the consensus of $3.12 billion. Base Bu...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...